| NYMX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||
Below is a table of the NYMX shares outstanding history going back to 8/13/2010:
Also see: NYMX Market Cap History NYMX YTD Return |
NYMX Shares Outstanding History — Nymox Pharmaceutical Share Count Over Time
As of 12/31/2020 Nymox Pharmaceutical has 77.96 million NYMX shares outstanding. Investors often track the NYMX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows NYMX share count trends over time, with 15 historical shares outstanding datapoints presented, dating back to 8/13/2010.
| NYMX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||
NYMX Historical Shares Outstanding: +8.93% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||
| NYMX Stock Price Chart |
| About Nymox Pharmaceutical Corp |
| Nymox Pharmaceutical is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia and the treatment of low-grade localized prostate cancer. Co. has developed and markets NicAlert™ and TobacAlert™, which are test strips for determining whether a person is using tobacco products (NicAlert™) or has been exposed to second-hand smoke (TobacAlert™). Both NicAlert™ and TobacAlert™ employ the patented technology of Co.'s subsidiary, Serex, Inc., to provide a read-out of levels of cotinine, a by-product of the body's breakdown of nicotine and generally regarded as the indicator of tobacco exposure for smokers and nonsmokers. We show 15 historical shares outstanding datapoints in our coverage of NYMX's shares outstanding history. Understanding the changing numbers of NYMX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like NYMX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching NYMX by allowing them to research NYMX shares outstanding history as well as any other stock in our coverage universe. |
| NYMX Current Stock Quote |
Quotes delayed 20 minutes  Free NYMX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| NYMX Share Performance |
| Shares Outstanding Peers |
| Nymox Pharmaceutical (NYMX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
OABI Shares Outstanding History OBIO Shares Outstanding History OBLN Shares Outstanding History OCGN Shares Outstanding History OCUL Shares Outstanding History OCUP Shares Outstanding History OCX Shares Outstanding History ODT Shares Outstanding History ODYS Shares Outstanding History OFIX Shares Outstanding History More Healthcare companies » |
NYMX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
